NL-OMON35370已完成不适用
The second INTEnsive blood pressure Reduction in Acute Cerebral haemorrhage Trial. An international randomised controlled trial to establish the effects of early intensive blood pressure lowering in patients with intracerebral haemorrhage. - Interact 2
niversitair Medisch Centrum Utrecht0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •a. 18 years or older.
- •b. Acute stroke due to sponataneous ICH, confirmed by clinical history and CT scan.
- •c. At least 2 separate blood pressure measurements of systolic blood pressure >=150 mmHg, and <=220 mmHg.
- •d. Able to commence assigned blood pressure treatment within 6 hours of stroke onset.
- •e. Able to be actively treated (not moribund).
- •(zie pagina 17 van het protocol)
排除标准
- •a. Known definite contraindication to an intensive BP lowering regimen (eg severe carotid, vertebral or cerebral arterial stenosis, known Moya Moya disease or Takayasu*s arteritis, high-grade stenotic valvular heart disease, or severe renal failure).
- •b. Known definite indication for an intensive BP lowering regimen that is similar or more intensive than the active treatment arm of this study (eg very high systolic BP >220 mmHg, hypertensive encephalopathy, or aortic dissection).
- •c. Definite evidence that the ICH is secondary to a structural abnormality in the brain (eg an AVM, intracranial aneurysm, tumour, trauma, or previous cerebral infarction) or previous thrombolysis.
- •d. Previous ischaemic stroke within 30 days.
- •e. A very high likelihood that the patient will die within the next 24 hours on the basis of clinical and/or radiological criteria (eg massive haematoma with mid-line shift of hemisphere or deep coma on presentation, defined by Glasgow Coma Scale Score of 3-5), (NB seizures occur commonly after the onset of ICH, so a reduction in the level of consciousness that isdisproportionate to the size of the haematoma may be secondary to epilepsy rather than mass effect from the ICH).
- •f. Known advanced dementia or significant pre-stroke disability (eg modified Rankin Score [mRS] of 3 or more).
- •g. Concomitant medical illness that would interfere with outcome assessments and follow-up (eg advanced cancer or respiratory disease).
- •h. Already booked for surgical evacuation of haematoma.
- •i. Previous participation in this trial or current participation in an investigational drug trial.
- •j. A high likelihood that the patient will not adhere to the study treatment and follow-up regimen.
研究者
相似试验
撤回
2 期
CALM-2 - Controlling and Lowering Blood Pressure with the MobiusHD*resistant Hypertensiondrug resistant high blood pressure10057166NL-OMON46497Vascular Dynamics33
已完成
4 期
An investigator initiated international, multicentre, stepped wedge cluster randomised study of a care bundle of physiological control strategies in acute intracerebral haemorrhage patients in comparison to usual careAcute spontaneous intracerebral haemorrhageSLCTR/2021/003The George Institute for Global Health (Australia) Beijing Representative Office
进行中（未招募）
不适用
A clinical trial to investigate reduced intensity post-operative treatment for HPV positive throat cancerOropharyngeal cancerEUCTR2014-003392-32-GBVelindre NHS Trust242
进行中（未招募）
1 期
Early stage clinical trial to investigate whether the Oxabact OC5 product reduces oxalate levels in the urine of patients with primary hyperoxaluria (a disease affecting the kidneys).Primary Hyperoxaluria (PH)MedDRA version: 17.0Level: PTClassification code 10020703Term: HyperoxaluriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2012-005606-22-DEOxThera AB24
进行中（未招募）
不适用
Early stage clinical trial to investigate whether the Oxabact OC5 product reduces oxalate levels in the urine of patients with primary hyperoxaluria (a disease affecting the kidneys).Primary Hyperoxaluria (PH)MedDRA version: 17.0Level: PTClassification code 10020703Term: HyperoxaluriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2012-005606-22-GBOxThera AB24